AstraZeneca has claimed UK approval for a new version of its respiratory triple therapy Trixeo Aerosphere that contains a propellant with a massively reduced global warming potential (GWP). The drug – ...
GSK has developed a new propellant technology for inhaler devices that drastically reduces their use of greenhouse gases, which perhaps surprisingly account for nearly half (49%) of the group’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback